Korean Circ J.  2020 Oct;50(10):904-906. 10.4070/kcj.2020.0352.

Coronary Microvascular Dysfunction: Is It Distinct Clinical Entity or Common Physiologic Pathway?

• Ahn JM

• KMID: 2507007
• DOI: http://doi.org/10.4070/kcj.2020.0352

Reference

1. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007; 356:830–840. PMID: 17314342.

2. Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014; 35:1101–1111. PMID: 24366916.

3. Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J. 2012; 33:2771–2782b. PMID: 22915165.

4. Lim HS, Seo KW, Yoon MH, Yang HM, Tahk SJ. Ischemia-based coronary revascularization: beyond anatomy and fractional flow reserve. Korean Circ J. 2018; 48:16–23. PMID: 29171198.

5. Fearon WF, Kobayashi Y. Invasive assessment of the coronary microvasculature: the index of microcirculatory resistance. Circ Cardiovasc Interv. 2017; 10:e005361. PMID: 29222132.

6. Lee JM, Choi KH, Doh JH, et al. Long-term patient prognostication by coronary flow reserve and index of microcirculatory resistance: international registry of comprehensive physiologic assessment. Korean Circ J. 2020; 50:890–903.

7. Lee JM, Jung JH, Hwang D, et al. Coronary flow reserve and microcirculatory resistance in patients with intermediate coronary stenosis. J Am Coll Cardiol. 2016; 67:1158–1169. PMID: 26965536.